Phoenix Life Sciences International Limited (PLSI) Research

Phoenix Life Sciences International Limited operates as a global healthcare solutions provider, conducting business in the United States and internationally. The company primarily concentrates on pioneering research, developing integrated programs, and producing goods aimed at the prevention and treatment of a broad spectrum of conditions. These include diabetes, pain, and various cancers, as well as psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. Its diverse product line encompasses oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. Established in 2009, the company was initially known as Stem Bioscience, Inc., before officially adopting the name Phoenix Life Sciences International Limited in May 2018. Its corporate headquarters are located in Las Vegas, Nevada.

Market snapshot

Symbol
PLSI
Price
$0.00
Day change
-99.99%
Market cap
$365.9K
P/E ratio
-0.00x
52-week range
1.0E-4-1.0E-4
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Achiko AG (ACHKF)
  • Digicann Ventures Inc. (AGFAF)
  • Alseres Pharmaceuticals, Inc. (ALSE)
  • CuraScientific Corp (CSTF)
  • Laxai Pharma, Ltd. (LAXAF)
  • Lotus Ventures Inc. (LTTSF)
  • NantHealth, Inc. (NHIQ)
  • SugarBud Craft Growers Corp. (SBUDF)

Open Phoenix Life Sciences International Limited (PLSI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.